405 related articles for article (PubMed ID: 22078979)
1. Effects of nebivolol or irbesartan in combination with hydrochlorothiazide on vascular functions in newly-diagnosed hypertensive patients: the NINFE (Nebivololo, Irbesartan Nella Funzione Endoteliale) study.
Vitale C; Marazzi G; Iellamo F; Spoletini I; Dall'Armi V; Fini M; Volterrani M
Int J Cardiol; 2012 Mar; 155(2):279-84. PubMed ID: 22078979
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.
Omboni S; Malacco E; Napoli C; Modesti PA; Manolis A; Parati G; Agabiti-Rosei E; Borghi C
Adv Ther; 2017 Apr; 34(4):784-798. PubMed ID: 28260186
[TBL] [Abstract][Full Text] [Related]
3. The beneficial effects of nebivolol on endothelial functions in arterial hypertension.
Celik T; Yilmaz MI
Int J Cardiol; 2012 Mar; 155(2):320-1. PubMed ID: 22222424
[No Abstract] [Full Text] [Related]
4. Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function.
Schiffrin EL; Park JB; Pu Q
J Hypertens; 2002 Jan; 20(1):71-8. PubMed ID: 11791028
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of nebivolol and valsartan on BP reduction and sleep apnoea activity in patients with essential hypertension and OSA.
Heitmann J; Greulich T; Reinke C; Koehler U; Vogelmeier C; Becker HF; Schmidt AC; Canisius S
Curr Med Res Opin; 2010 Aug; 26(8):1925-32. PubMed ID: 20560730
[TBL] [Abstract][Full Text] [Related]
6. Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness.
Koumaras C; Tziomalos K; Stavrinou E; Katsiki N; Athyros VG; Mikhailidis DP; Karagiannis A
J Am Soc Hypertens; 2014 Feb; 8(2):74-82. PubMed ID: 24139833
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M;
Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial.
Radchenko GD; Sirenko YM; Kushnir SM; Torbas OO; Dobrokhod AS
Vasc Health Risk Manag; 2013; 9():535-49. PubMed ID: 24109189
[TBL] [Abstract][Full Text] [Related]
9. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
Polónia J; Barbosa L; Silva JA; Bertoquini S
Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
[TBL] [Abstract][Full Text] [Related]
10. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
Weiss RJ; Stapff M; Lin Y
Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
[TBL] [Abstract][Full Text] [Related]
11. Irbesartan and hydrochlorothiazide association in the treatment of hypertension.
Derosa G; Ferrari I; Cicero AF
Curr Vasc Pharmacol; 2009 Apr; 7(2):120-36. PubMed ID: 19355995
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Nebivolol and Irbesartan on Ambulatory Aortic Blood Pressure and Arterial Stiffness in Hemodialysis Patients with Intradialytic Hypertension.
Theodorakopoulou M; Loutradis C; Bikos A; Angeloudi E; Schoina M; Raptis V; Liakopoulos V; Papagianni A; Sarafidis P
Blood Purif; 2021; 50(1):73-83. PubMed ID: 33017836
[TBL] [Abstract][Full Text] [Related]
13. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
Bobrie G;
Clin Ther; 2012 Aug; 34(8):1720-34.e3. PubMed ID: 22853847
[TBL] [Abstract][Full Text] [Related]
14. Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study.
Grassi G; Seravalle G; Brambilla G; Dell'Oro R; Trevano FQ; Fici F; van Bortel L; Mancia G
Adv Ther; 2017 Jan; 33(12):2173-2187. PubMed ID: 27771847
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness.
Kampus P; Serg M; Kals J; Zagura M; Muda P; Karu K; Zilmer M; Eha J
Hypertension; 2011 Jun; 57(6):1122-8. PubMed ID: 21536983
[TBL] [Abstract][Full Text] [Related]
16. Safety and tolerability of fixed-dose irbesartan/hydrochlorothiazide for rapid control of severe hypertension.
Neutel JM; Franklin SS; Bhaumik A; Lapuerta P; Oparil S
Clin Exp Hypertens; 2009 Oct; 31(7):572-84. PubMed ID: 19886855
[TBL] [Abstract][Full Text] [Related]
17. Singular and combined effects of nebivolol and lifestyle modification on large artery stiffness in hypertensive adults.
Werner TJ; Boutagy NE; Osterberg KL; Rivero JM; Davy KP
Ther Adv Cardiovasc Dis; 2013 Dec; 7(6):285-92. PubMed ID: 24265181
[TBL] [Abstract][Full Text] [Related]
18. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection.
Mahmud A; Feely J
Am J Hypertens; 2008 Jun; 21(6):663-7. PubMed ID: 18437130
[TBL] [Abstract][Full Text] [Related]
19. Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients.
Kaiser T; Heise T; Nosek L; Eckers U; Sawicki PT
J Hypertens; 2006 Jul; 24(7):1397-403. PubMed ID: 16794490
[TBL] [Abstract][Full Text] [Related]
20. Predictors of blood pressure response to angiotensin receptor blocker/diuretic combination therapy: a secondary analysis of the irbesartan/hydrochlorothiazide blood pressure reductions in diverse patient populations (INCLUSIVE) study.
Saunders E; Cable G; Neutel J
J Clin Hypertens (Greenwich); 2008 Jan; 10(1):27-33. PubMed ID: 18174768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
